Benzinga - Fri, 08 Jan 2021 19:01:51 -0400
Benzinga - Wed, 06 Jan 2021 00:57:54 -0400
Benzinga - Fri, 01 Jan 2021 12:40:09 -0400
Benzinga - Wed, 30 Dec 2020 18:58:38 -0400
Benzinga - Wed, 30 Dec 2020 12:44:09 -0400
Benzinga - Mon, 28 Dec 2020 19:02:12 -0400
Benzinga - Thu, 24 Dec 2020 09:46:22 -0400
Benzinga - Wed, 23 Dec 2020 18:04:16 -0400
Benzinga - Tue, 22 Dec 2020 17:44:08 -0400
Benzinga - Fri, 18 Dec 2020 18:46:56 -0400
Benzinga - Wed, 16 Dec 2020 19:09:36 -0400
Benzinga - Tue, 15 Dec 2020 18:11:55 -0400
Benzinga - Mon, 14 Dec 2020 18:53:58 -0400
load more
Zelira Therapeutics Ltd, formerly Zelda Therapeutics Ltd is an Australia-based biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in a breast, brain, and pancreatic cancer.

Related Companies

TickerCompanyChg %Mkt Cap
ZLDAFZelira Therapeutics0%96M

Zelira Therapeutics Company Questions & Answers

Q

How do I buy Zelira Therapeutics (ZLDAF) stock?

A

You can purchase shares of Zelira Therapeutics (OTC: ZLDAF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zelira Therapeutics's (ZLDAF) main competitors?

A

There are no as such competitors for Zelira Therapeutics.

Q

What is the target price for Zelira Therapeutics?

A

There is no analysis for Zelira Therapeutics

Q

How much is Zelira Therapeutics (ZLDAF) stock ?

A

The stock price for Zelira Therapeutics (OTC: ZLDAF) is $0.081 last updated Tue Jan 26 2021 20:25:43 GMT+0000 (Coordinated Universal Time).

Q

When is the next Zelira Therapeutics (ZLDAF) dividend?

A

There are no upcoming dividends for Zelira Therapeutics.

Q

When is Zelira Therapeutics (OTC:ZLDAF) reporting earnings?

A

There are no earnings for Zelira Therapeutics

Q

When is the upcoming split for ZLDAF?

A

There is no upcoming split for Zelira Therapeutics.